IPHA NASDAQ
Innate Pharma S.A.
1W: -8.2%
1M: -28.1%
3M: -16.6%
YTD: -14.3%
1Y: -21.2%
3Y: -39.5%
5Y: -76.7%
$1.56
-0.03 (-1.89%)
Weekly Expected Move ±6.7%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$6M
Revenue
-91.4% YoY
$-94M
Net Income
+3.3% YoY
$-86M
Free Cash Flow
-68.7% YoY
0.0%
Gross Margin
-692.1%
Op. Margin
-630.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE1600.0%
ROA-100.5%
ROIC254.7%
Valuation
P/E-2.6
P/B-3.0
EV/EBITDA0.0
Leverage
Debt/Equity-0.50
Current Ratio0.60
Interest Cov.-32.9x
Quality Scores
Piotroski F2/9
Altman Z—
Beneish M35.59